SAN DIEGO - (Business Wire) Executives from XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, will speak at two highly regarded laboratory conferences in April sharing insights and expertise regarding cash flow and reimbursement strategies for laboratories and molecular diagnostic companies.
On April 27, XIFIN CEO and executive chairman Lâle White and Rina Wolf, Vice President of Commercialization Strategies, Consulting and Industry Affairs for XIFIN, will co-present at the 15th annual Executive War College, April 27-28, 2010 in New Orleans, LA on the topic, "Maintaining Your Lab's Cash Flow: Ways to Legally Neutralize Emerging Federal Policies that Will Be Financially Corrosive to Laboratories."
The Executive War College is the premier conference of its kind, bringing together laboratory executives, pathologists and industry leaders and featuring more than 70 speakers, topics and sessions covering laboratory strategy, operations and management.
In addition, Wolf will join leading molecular experts and executives from the nation’Âs top molecular labs to present the session, ’Â¬Reimbursement Strategies for Molecular Diagnostics’Â® on April 15th at the Fifth Annual Washington G-2 Reports Molecular Diagnostics 2010 conference being held April 14-16, 2010 in Cambridge, MA. Wolf will demonstrate how reimbursement for molecular testing is different from routine laboratory testing, and highlight common issues encountered in commercialization strategies and reimbursement for molecular testing.
More than half of the molecular diagnostic claims generated by specialty laboratories in the United States are processed through the XIFIN system and seven of the industry’Âs 10 largest clinical labs currently work with XIFIN to automate their billing process, improve cash collections, better manage complex reimbursement requirements and reduce the costs associated with regulatory compliance.
White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S.
Wolf is a leading authority in the field of laboratory commercialization and reimbursement, with over 20 years of experience in the diagnostic laboratory industry, specializing in molecular diagnostic laboratories. She is a former president and board member of the California Clinical Laboratory Association and is an active participant with the American Clinical Laboratory Association and the Personalized Medicine Coalition.
XIFIN has processed more than 150 million claims for a variety of diagnostic service providers across various healthcare segments including clinical, hospital outreach, anatomic pathology, molecular diagnostics, therapeutic pain management, radiology and more.